Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia

ClinicalTrials.gov ID: NCT00088634

Public ClinicalTrials.gov record NCT00088634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 6:43 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 6-week in-patient and out-patient study to test the effectiveness and safety of a new medication in the treatment of schizophrenia

Study identification

NCT ID
NCT00088634
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
180 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Dec 2004 (Actual)
Completion
Dec 2004 (Actual)
Last update posted
Apr 8, 2016

2004

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Birmingham Alabama 35209 —
Summit Research Group Little Rock Arkansas 72211 —
Comprehensive NeuroScience Cerritos California 90703 —
Collaborative Neuro Science Network, Inc. Garden Grove California 92845 —
Optimum Health Services La Mesa California 91942 —
California Clinical Trials San Diego California 92123 —
CNRI, LLC San Diego San Diego California 92126 —
Pacific Clinical Research Upland California 91786 —
Comprehensive NeuroScience, Inc Washington D.C. District of Columbia 20016 —
Segal Institute for Clinical Research North Miami Florida 33161 —
The Segal Institute North Miami Florida 33161 —
University of South Florida, Department of Psychiatry and Behavioral Medicine Tampa Florida 33613 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Comprehensive Neuroscience, Inc. Hoffman Estates Illinois 60194 —
Robert Lynn Horne, MD, Suite 4 Las Vegas Nevada 89102 —
CNS Research Institute Clementon New Jersey 08021 —
Quantum Clinical Services Group Philadelphia Pennsylvania 19139 —
Community Clinical Research Austin Texas 78729 —
Future Search Trials Austin Texas 78756 —
Claghorn-Lesem Research Clinic Bellaire Texas 77401 —
InSite Clinical Research DeSoto Texas 75115 —
CBH Health, L.L.C - Dominion Hospital Falls Church Virginia 22044 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00088634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2016 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00088634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →